Navigation Links
First proof of principle for treating rare bone disease
Date:11/9/2011

PHILADELPHIA - Scientists at Penn's Perelman School of Medicine Center for Research in FOP and Related Disorders have developed a new genetic approach to specifically block the damaged copy of the gene for a rare bone disease, while leaving the normal copy untouched.

Lead author Josef Kaplan, PhD, postdoctoral fellow; and senior authors Eileen M. Shore, PhD, and Frederick S. Kaplan, MD, both from the Department of Orthopaedic Surgery, published this new proof-of-principle approach for treating the disease, called FOP, in the online edition of Gene Therapy.

FOP, fibrodysplasia ossificans progressiva, is a rare genetic disorder of progressive extra bone formation for which there is presently no cure. It is caused by a mutation in the gene for ACVR1/ALK2, a bone morphogenetic protein (BMP) receptor that occurs in all classically affected individuals. Individuals who have FOP harbor one normal copy and one damaged copy of the ACVR1/ALK2 gene in each cell. The mutation increases the amount of BMP in cells to greater than normal levels, which initiates the transformation of muscles and cartilage into a disabling second skeleton of bone.

Using a special type of RNA molecule engineered to specifically silence the damaged copy of the gene rather than the normal copy -- a process known as RNA interference, or RNAi -- the scientists restored the cellular function caused by the FOP mutation by ridding cells of the mutant ACVR1/ALK2 mRNA. Cells were essentially left with only normal copies of ACVR1/ALK2 mRNA, thus adjusting the protein's activity to normal, similar to that of cells without the FOP mutation.

The human cells used in the experiments were adult stem cells obtained directly from discarded baby teeth donated by FOP patients. These contained the exact combination of damaged and normal ACVR1/ALK2 receptor proteins found in all classically affected FOP patients worldwide. The discarded teeth were obtained from FOP pedi
'/>"/>

Contact: Karen Kreeger
karen.kreeger@uphs.upenn.edu
215-349-5658
University of Pennsylvania School of Medicine
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Medical Training School, Pima Medical Institute Offering First Bachelor's Degree Program
2. Retired Military Brass Support First Ladys Call to Reduce Child Obesity, Improve Nutrition
3. NASBE Supports First Lady Michelle Obama in Fight Against Childhood Obesity
4. PolicyLink CEO Angela Glover Blackwell Released the Following Statement on First Lady Michelle Obamas Childhood Obesity Initiative
5. MSU launches first anti-counterfeiting research program
6. AMA Joins First Lady in Fight Against Childhood Obesity
7. National Wildlife Federation Says Outdoor Time for Kids Can Help First Lady Achieve Her “Let's Move” Goal
8. First blinded study of venous insufficiency prevalence in MS shows promising results
9. Akron Institute of Herzing University Launches Its First Bachelors Degree Programs to Prepare Students for Even Greater Success in Business, Health Care and IT
10. First Gene Variants Linked to Stuttering Discovered
11. FAB-HOMES™ Presents First Passive House Collection
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
First proof of principle for treating rare bone disease
(Date:8/22/2014)... 22, 2014 Beat Eczema , ... can use natural methods to completely cure the eczema ... attention of Shane Michaels, prompting an investigative review. ... the skin, it can still be extremely debilitating and ... “The intense itching and pain that it causes on ...
(Date:8/22/2014)... time an oncogenic somatic mutation at amino acid 918 ... identified in small cell lung cancer (SCLC) tumors and ... produced increased intracellular signaling and cell growth. , SCLC ... 15% of all lung cancers and is strongly associated ... has been extensively examined for genomic alterations and targeted ...
(Date:8/22/2014)... Paying tuition and other related educational expenses ... for four nurse educators pursuing advanced degrees, thanks to ... Foundation for Nursing Education . This year’s recipients – ... than in 2013, thanks to these named NLN Foundation ... Marcil Endowment Funds, both donated by Kathy Mershon; the ...
(Date:8/22/2014)... August 22, 2014 Testosterone treatment ... in U.S. courts on behalf of men who ... use of prescription low testosterone therapies, Bernstein Liebhard ... claim was filed against Pfizer Inc. on July ... life-threatening heart issues due to his use of ...
(Date:8/22/2014)... Hudson County, NJ (PRWEB) August 22, 2014 ... that a leading specialist in Internal Medicine, Geriatrics, ... joined the network, CarePoint Health Medical Group. Their ... of highly skilled and experienced physicians comprise CarePoint ... doctors and practices in Hudson County, representing a ...
Breaking Medicine News(10 mins):Health News:Beat Eczema: Review Exposes Susan Clark’s Guide to Curing Eczema Naturally 2Health News:Novel oncogenic RET mutation found in small cell lung cancer 2Health News:NLN Foundation for Nursing Education Announces 2014 Faculty Scholarship Awards 2Health News:NLN Foundation for Nursing Education Announces 2014 Faculty Scholarship Awards 3Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 2Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 3Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 4Health News:Dr. Reisner Joins CarePoint Health Medical Group 2
... to Assure ... POWELL, Ohio, June 2 Click4Care, Inc., a ... payers,providers and patients, today announced that Cariten Healthcare, one ... subsidiary of,Covenant Health, has selected ThinkHealth for its medical ...
... Awarded Seven Gold Healthcare Advertising Marketing Awards, ... record number of over 4,400,entries, the 25th ... awards to Publicis Indianapolis and St. Vincent ... television), and marketing,work. Additionally, both entities won ...
... In a multi-site study, Oregon Health & Science University ... also known as MDX-010, works to stimulate the body,s own ... to be effective in study participants with a serious type ... and was resistant to hormonal treatment and, in some cases, ...
... (BioMedical Enterprises, Inc.),a privately held medical device company and ... launch of the OSSAnchor(TM),Grip, a nitinol implant designed to ... the first in the family of OSSAnchor(TM) nitinol soft,tissue ... Grip is a,nitinol implant with aggressive barbs on the ...
... Care Association Raising Profile of Key Issue Impacting,Texas Seniors, ... June 2 With just more than,five months until ... by Baselice Associates finds 57% of voters less likely ... she opposed increasing the amount,the state pays nursing homes ...
... Entitled, ,Ingenuity at Work, Discusses Abbott,s, Contributions to ... ABBOTT PARK, Ill., June 2 Abbott (NYSE: ... Report, "Ingenuity at Work,",which is available online at ... access to care, innovation, science,education and the environment., ...
Cached Medicine News:Health News:Click4Care Signs Award-Winning 500,000-Member Health Plan 2Health News:Publicis Indianapolis and St. Vincent Hospital Win the Gold 2Health News:OHSU Cancer Institute finds that drug stimulated immune system in prostate cancer 2Health News:OHSU Cancer Institute finds that drug stimulated immune system in prostate cancer 3Health News:BME (BioMedical Enterprises, Inc.) Announces U.S. Launch of the OSSAnchor(TM) Grip Nitinol Soft Tissue Anchor 2Health News:Texas Eldercare Poll: 57 Percent Less Likely to Back Local Legislator if They Oppose Medicaid Rate Boost 2Health News:Texas Eldercare Poll: 57 Percent Less Likely to Back Local Legislator if They Oppose Medicaid Rate Boost 3Health News:Abbott Releases 2007 Global Citizenship Report Highlighting Strong Commitment to Access to Health Care 2Health News:Abbott Releases 2007 Global Citizenship Report Highlighting Strong Commitment to Access to Health Care 3
(Date:8/21/2014)... , Aug. 21, 2014  Aptuit LLC announces ... Lafayette, Indiana , has enhanced its capabilities ... of small and large molecules, including biologic drugs, ... Bruker maXisPlus Q-TOF mass spectrometer. In ... CEO, Aptuit, said, "The expanded large molecule capability ...
(Date:8/21/2014)... Aug. 21, 2014 The spinal column is one ... body. Signals carried to and from the brain through the ... nervous system. Injury or ailment here can be life altering, ... loss of control over their body. Though back injury and ... life, there are more options available to make things better ...
(Date:8/21/2014)... , Aug. 21, 2014 /PRNewswire-iReach/ -- ... Equipment, Inc. for the third straight year, No. ... 500|5000, an exclusive ranking of the nation,s fastest-growing ... look at the most important segment of the ... Timberland, Dell, Domino,s Pizza, LinkedIn, Zillow, and many ...
Breaking Medicine Technology:Aptuit SSCI Adds Ultra High Resolution Q-TOF Mass Spectrometer for Large & Small Molecule Analyses 2Don't Live in Pain: Four Life Improving Benefits of Back Surgery 2Carolina's HME Named for Third Straight Year to Inc. Magazine's List of America's Fastest-Growing Private Companies--the Inc. 5000 2Carolina's HME Named for Third Straight Year to Inc. Magazine's List of America's Fastest-Growing Private Companies--the Inc. 5000 3
... 17 Cyberonics, Inc. (Nasdaq: CYBX ) today ... Compensation Committee of its Board of Directors approved an award ... of 800 shares of restricted stock and an option to ... share, the closing price of the company,s stock on September ...
... Sept. 17 Teikoku Pharma USA, Inc., an international ... and Drug Administration (FDA) has accepted for review the ... patch of Aricept®, a leading medication for the treatment ... weekly Aricept(r) patch based on a license agreement executed ...
Cached Medicine Technology:FDA Accepts Aricept® Patch (Donepezil Transdermal System) NDA for Review 2
The rectangular large-field lens of the 2631 are ideal for reading and writing....
The Multi-Purpose Stand Magnifier is the most versatile stand magnifier. The stand has multiple configurations allowing for all situations where hands-free magnification is needed....
Thinprofile design eyelid implants....
Bausch & Lomb magnifiers incorporates precision optics and patented ergonomic designs for increased clarity and comfort during use....
Medicine Products: